Park Dental Partners, Inc. Common Stock (PARK) Fair Value & Analysis
Healthcare · US · Market cap $82.4M · ISIN US7004021009
What is Park Dental Partners, Inc. Common Stock really worth?
Park Dental Partners, Inc. Common Stock
PARK · US
A solid business, but trading 17% above our fair value of $17.70.
Strengths
Risks
Fair value as of: Aug 19, 2026
From 14 valuation models · updated 12 days ago
Fair value updated Aug 19, 2026, revised from $17.67 to $17.70 (+0.2%) since Aug 13, 2026. Share price +16.0% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($17.70). The favourable scenario is already priced in.
- Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
- The models converge in a tight band ($17.70 to $17.70), unusually little disagreement for a valuation.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (9 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 19, 2026.
How to read this chart
9‑month range $10.25 – $23.05 · fair‑value band $17.70 – $17.70 · the $20.74 price screens above the $17.70 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Aug 19, 2026.
Analysis
Park Dental Partners, Inc. Common Stock (PARK) currently trades at $20.74, while our model-based Fair Value estimate is $17.70, implying the stock looks roughly 17.2% overvalued today. The Quality Score stands at 52/100 (solid quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $17.72 per share, and 0 of the 14 models we run sit above the $20.74 price. Bear case: the Earnings-Based group reads lowest at $17.68, and 14 of the 14 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, Park Dental Partners, Inc. Common Stock generated revenue of $248M at a net margin of −0.9%. Revenue grew 6.2% year over year. It earns a return on equity of −21.9%. The balance sheet holds a net cash position of $25.1B. Fundamentals as of Aug 19, 2026
Our scenario range runs from $17.70 (bear case) to $17.70 (bull case); at $20.74, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high and 118% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −15%, PARK screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 14 models by family
Widest divergence: DCF Models ($17.72) versus Asset-Based ($0.0103). Highest evidence: FCF DCF (75).
Notify me when PARK reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 47
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Park Dental Partners, Inc. operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona.
Full company description
Park Dental Partners, Inc. operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona. The company offers general and specialty dental care services, such as dentist and hygiene, oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. It provides clinical team members, administrative personnel, and facilities and equipment to its affiliated general and multi-specialty dental practices. The company was founded in 1972 and is headquartered in Roseville, Minnesota.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2025 · reported fiscal years
Park Dental Partners, Inc. Common Stock reported revenue of $244M in FY2025 versus $224M in FY2023, a compound +4.6%/yr. Reported net income was −$358K in FY2025.
PARK screens 17% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 267 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $417.82 | $547.67 | +31% |
| Fresenius SE FRE | €45.25 | €32.15 | −29% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 241.00 SAR | 112.37 SAR | −53% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | −46% |
| Tenet Healthcare Corporation THC | $266.80 | $330.25 | +24% |
| DaVita Inc DVA | $180.68 | $186.49 | +3% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,818 | ₹2,955 | −66% |
| Fresenius Medical Care AG FME | €39.92 | €71.28 | +79% |
| Aier Eye Hospital Group 300015 | ¥8.25 | ¥7.67 | −7% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,005 | ₹284.87 | −72% |
Compare Park Dental Partners, Inc. Common Stock with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Park Dental Partners, Inc. Common Stock (PARK) overvalued or undervalued?
What is the fair value of PARK?
What is the quality score of PARK?
What is the revenue of Park Dental Partners, Inc. Common Stock (PARK)?
What is the net profit margin of PARK?
Watch Park Dental Partners, Inc. Common Stock in the live analysis
One click puts Park Dental Partners, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.